EastHORN is pleased to announce its participation at this year’s DIA Annual Meeting, an event held on 23rd – 27th June 2019 | San Diego Convention Center, San Diego, USA.
The Drug Information Association Global Annual Meeting (DIA 2019) is designed to help improve health globally through the advancement of lifesaving medicines and technologies. DIA 2019 Global Annual Meeting will host more than 6,000 professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries around the globe and 450+ exhibiting companies. Whether you’re interested in Clinical Operations, Patient Engagement, or Regulatory Affairs, you will find sessions that advance your profession.
Who will welcome you to our booth (#1349):
Malgorzata Szerszeniewska, Chief Executive Officer
Co-founder of EastHORN, previously, she was president of AbCRO, Inc., an American-owned CRO operating in Europe. Prior to that Dr. Szerszeniewska spent more than 10 years at Covance, where she held various positions including Regional Resource Manager, Project Manager, Director of Strategic Development and Clinical Operations in Europe, and was responsible for the development of the company’s Clinical Development Services in the European region.
Malgorzata is based at EastHORN’s offices in Poland.
Iain Gordon, Chief Business Officer
Initially with big pharma before transitioning into contract research at the turn of the millennium, Iain Gordon has been involved in the pharmaceutical industry for more than 20 years. Since the first tentative steps into Poland and Hungary in the 90’s he has enjoyed and been a key part of the spectacular growth in clinical services across Europe and beyond. Senior management roles as European Head and Global VP of Business Development have enabled Iain to be at the leading edge of business and corporate development within the global CRO industry.
Iain is based at EastHORN’s offices in the UK.
Mark Anderson, Senior Director of Business Development
For the past 21 years, Mark has worked closely with biotech and pharmaceutical clients around the globe helping them to successfully plan and execute their clinical trials. Mark started his career in Clinical Research in 1997, firstly as a CRA and then as a Project Manager before transitioning into Business Development in 2003. Although located in Europe for the majority of his career (now based in Dublin, Ireland), Mark also spent 5 years in Boston between 2005-2010 and is looking forward to seeing old friends at DIA as well as making new ones.